Rapid and slow disease progression in HIV-1 infected persons in Madrid, Spain;Progresión rápida y lenta de la infección por el virus de la inmunodeficiencia humana tipo 1 en una población de sujetos seropositives de Madrid

Medicina Clinica

Volumn 107, Issue 20, 1996, Pages 761-766

  Soriano, V ^a,c   Martin R ^a   Del Romero, J ^a   Castilla, J ^b   Bru, F ^a   Bravo, R ^a   Gutierrez M ^a   Martinez P ^a   Valencia, E ^a   Garcia S ^a   Mas, A ^a   Moreno, V ^a   Laguna, F ^a   Rodriguez C ^a   Sabin M L ^a   Gonzalez Lahoz J ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; COMORBIDITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MULTICENTER STUDY; SPAIN; TIME; VIROLOGY; VIRUS HEPATITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BIOLOGICAL MARKERS; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HEPATITIS, VIRAL, HUMAN; HIV SEROPOSITIVITY; HUMANS; MALE; SPAIN; TIME FACTORS;

EID: 0030574374     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Muñoz A, Wang M, Bass S, Taylor J, Kingsley L, Chmiel J et al. Acquired immunodeficiency syndrome (AIDS)-free time after HIV-1 seroconversion in homosexual men. Am J Epidemiol 1989; 130: 530-539.
2. Jason J, Lui K, Ragni M, Hessol N, Darrow V. Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA 1989; 261: 725-727.
3. Rutherford G, Lifson A, Hessol IN, Darrow W, O'Malley P, Buchbinder S et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. Br Med J 1990; 301: 1.183-1.188.
4. Altisent C, Ayestarán A, Tusell J, Oliveras J, Montoro J, Vila M. Progresión de la infección por el VIH en una cohorte de hemofilicos durante un periodo de 11 años. Med Clin (Barc) 1995; 104: 411-414.
5. Muñoz A, Kirby A, He Y, Margolick J, Visscher B, Rinaldo C et al. Long-term survivors with HIV-1 infection: incubation period and longitudina patterns of CD4+ lymphocytes. J AIDS 1995; 8: 495-505.
6. Lee C, Webster A, Griffiths P, Kernoff P. Symptomless HIV infection after more than ten years. Lancet 1991; 335: 425-426.
7. Bulterys M, Nzabihimana E, Chao A, Bugingo G, Musekera J, Saah A et al. Long-term survival among HIV-1-infected prostitutes. AIDS 1993; 7: 1.269.
8. Sheppard H, Lang W, Ascher M, Vittinghoff E, Winkelstein W. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 1993; 7: 1.159-1.166.
9. Buchbinder S, Katz M, Hessol N, O'Malley P, Holmberg S. Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8: 1.123-1.128.
10. Easterbrook P. Non-progression in HIV infection. AIDS 1994; 8: 1.179-1.182.
11. Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992; 340: 863-867.
12. Isaksson B, Albert J, Chiodi F, Furucrona A, Krook A, Putkonen P. AIDS two months after primary HIV infection. J Infect Dis 1988; 158: 866-867.
13. McLean K, Holmes D, Evans B, McAlpine L, Thorp R, Parry J et al. Rapid clinical and laboratory progression of HIV infection. AIDS 1990; 4: 369-371.
14. Phair J, Jacobson L, Detels R, Rinaldo C, Saah A, Schrager L et al. Acquired immune deficiency syndrome occurring within 5 years of infection with HIV type 1: the Multicenter AIDS Cohort Study. J AIDS 1992; 5: 490-496.
15. Soriano V, Heredia A, Bravo R, Gutiérrez M, González-Lahoz J. Progresión rápida a sida en un paciente infectado con una cepa del VIH-1 formadora de sincitios. Med Clin (Barc) 1995; 105: 99-100.
16. Levy J. HIV pathogenesis and long-term survival. AIDS 1993; 7: 1.401-1.410.
17. Schrager L, Young J, Fowler M, Mathieson B, Vermund S. Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 1994; 8(Supl 1): 95-108.
18. Soriano V, Martin R, Del Romero J. Progresión rápida y lenta de la infección por VIH. Rev Clin Esp 1995; 195: 645-653.
19. Soriano V, González-Lahoz. VIH sin SIDA pero no SIDA sin VIH. Med Clin (Barc) 1995; 105: 172-173.
20. Revilla T, Pérez ML, Jiménez C, Fernández S, Baquero M. Descripción de 7 casos de infección por HIV-1 con serología positiva en los años 1980-81-82 [resumen]. XII Congreso Nacional de la Asociación Española de Microbiología. Pamplona 24-27 de septiembre de 1989 [Libro de resúmenes]; 186.
21. Cao Y, Qin L, Zhang L, Safrit J, Ho D. Virologic and immunologic characterization of long-term survivors of HIV type 1 infection. N Engl J Med 1995; 332: 201-208.
22. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen O, Demarest J et al. Studies in subjects with long-term nonprogressive HIV infection. N Engl J Med 1995; 332: 209-216.
23. Bravo R, Soriano V, Martin R, Del Romero J, Dronda F, Gutiérrez M et al. Cuantificación de la viremia por el VIH en pacientes con progresión rápida y lenta de la enfermedad. Med Clin (Barc) 1995; 104: 530-534.
24. CDC. Interpretation and use of the Western blot assay for serodiagnosis of HIV type 1 infections. MMWR 1989; 38: 1-7.
25. Soriano V, Gutiérrez M, Tuset C. Evaluación de diferentes criterios de interpretación del Western blot para el diagnóstico de la infección por el VIH. Med Clin (Barc) 1993; 100: 561-566.
26. Kirchhoff F, Greenough T, Brettler D, Sullivan J, Desrosiers R. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995; 332: 228-232.
27. Greenough T, Somasundaran M, Brettler D, Hesselton R, Alimenti A, Kirchhoff F et al. Normal immune function and inability to isolate virus in culture in an individual with long-term HIV type 1 infection. AIDS Res Hum Retroviruses 1994; 10: 395-403.
28. Melnick S, Sherer R, Louis T. Survival and disease progression according to gender of patients with HIV infection. JAMA 1994; 272: 1.915-1.921.
29. Ronald P, Robertson J, Elton R. Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS 1994; 8: 339-343.
30. Torres M, Ruiz M, Fernández M, Pérez C, Fernández E, Ugarte I et al. Cambios en la vía de administración de la heroína y frecuencia de infección por el VIH. Med Clin (Barc) 1995; 104: 249-252.
31. Medrano L, Nájera R. II Reunión del Programa Europeo de Serovigilancia del VIH sobre aspectos de la Epidemiología Molecular del VIH en Europa. Pub SEISIDA 1995; 6: 61-64.
32. Wei X, Ghosh S, Taylor M, Johnson V, Emini E, Deutsch P et al. Viral dynamics in HIV type 1 infection. Nature (Lond) 1995; 373: 117-122.
33. Ho D, Neumann A, Pereison A, Chen W, Leonard J, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes n HIV-1 infection. Nature (Lond) 1995; 373: 123-126.
34. Wain-Hobson S. Virological mayhem. Nature (Lond) 1995; 373: 102.
35. Coffin J. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995; 267: 483-489.
36. Erice A, Mayers D, Strike D. Primary infection with zidovudine-resistant HIV type 1. N Engl J Med 1993; 328: 1.163-1.165.
37. Veenstra J, Schuurman R, Cornelissen M, Van't Wout A, Boucher C, Schuiternaker H et al. Transmission of zidovudine-resistant HIV type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus. Clin Infect Dis 1995; 21: 556-560.
38. D'Aquila R, Johnson V, Welles S, Japour A, Kuritzkes D, De Gruttola V et al. Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. Ann Intern Med 1995; 122: 401-408
39. Fong I, Read S, Wainberg M, Chia W, Major C. Alcoholism and rapid progression to AIDS after seroconversion. Clin Infect Dis 1994; 19: 337-338.
40. Kaslow R, Blackwelder W, Ostrow D. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1 positive individuals. A report from the Multicenter AIDS Cohort Study. JAMA 1989; 261: 3.424-3.429.
41. Coates R, Farewell V, Raboud J, Read S, MacFadden D, Calzavara L et al. Cofactors of progression to AIDS in a cohort of male sexual contacts of men with HIV disease. Am J Epidemiol 1990, 132: 717-722.
42. Van Griensven G, De Vroome E, De Wolf F. Risk factors for progression of HIV infection among seroconverted and seropositive homosexual men. Am J Epidemiol 1990; 132: 203-210.
43. Westerberg V. Alcohol measuring scales may influence conclusions about the role of alcohol in HIV risk and progression to AIDS. Am J Epidemiol 1992; 135: 719-725.
44. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994; 344: 193-194.
45. Serafini M, Ghiselli A, Ferro-Luzzi A. Red wine, tea, and antioxidants. Lancet 1994; 344: 626.
46. Roselle G, Medenhall C. Alteration of in vitro human lymphocyte function by ethanol, acetaldehyde and acetate. J Clin Lab Immunol 1982; 9: 33-37.
47. McManus T, Wetherburn P. Alcohol, AIDS and immunity. Br Med Bull 1994; 50: 115-123.
48. Bukrinsky M, Stanwick T, Dempsey M, Stevenson M. Quiescent T lymphocytes as an inducible reservoir in HIV-1 infection. Science 1991; 254: 423-426.
49. Embretson J, Zupancic M, Ribas J, Burke A, Racz P, Tenner-Racz K et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (Lond) 1993; 362: 359-362.
50. Fauci A. Multifactorial nature of HIV disease: implications for therapy. Science 1993; 262: 1.011-1.018.
51. Andrieu J, Lu W, Levy R. Sustained increases in CD4 cell counts in asymptomatic HIV type 1 seropositive patients treated with prednisolone for one year. J Infect Dis 1995; 171: 523-527.
52. Weber J, Galpin S. Cyclosporin A. Nature (Lond) 1995; 375: 198.
53. Mohs M, Watson R. Ethanol induced malnutrition: a potential cause of immunosuppression during AIDS. Prog Clin Biol Res 1990; 325: 433-444.
54. Des Jarlais D, Friedman S, Marmor M, Cohen H, Mildvan D, Yancovitz S et al. Development of AIDS, HIV seroconversion, and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS 1987; 1: 105-111.
55. Peterson P, Sharp B, Gekker G, Portoghese P, Sannerud K, Balfour H. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990; 4: 869-873.
56. Artenstein A, VanCott T, Mascola J, Carr J, Hegerich P, Gaywee J et al. Dual infection with HIV type 1 of distinct envelope subtypes in humans. J Infect Dis 1995; 171: 805-810.
57. Carré N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994; 8: 797-802.
58. Rosenberg P, Goedert J, Biggar R. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994; 8: 803-810.
59. Kotier D, Tierney A, Wang J, Pierson R. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444-447.
60. Nieman R, Flemming J, Coker R. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 1993; 7: 705-710.
61. Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C et al. Activation of human immunodefiency virus type 1 by DNA damage in human cells. Nature (Lond) 1988; 333: 78-81.
62. Stein D. Herpes virus infections, HIV, and disease progression. AIDS Clin Care 1995; 7: 11-18.
63. Tikjob G, Russel M, Petersen C. Seronegative secondary syphilis in a patient with AIDS: identification of Treponema pallidum in biopsy specimen. J Am Acad Dermatol 1991; 24: 506-508.
64. Porter S, Sande M. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1.643-1.648.